Teriflunomide treatment reduces B cells in patients with MS

Conclusions:
In our small cohort, teriflunomide treatment affects mainly and significantly on B-cell numbers, while having a milder effect on T-cell numbers. Larger cohorts are necessary to confirm these findings and understand the effect of teriflunomide on the functionality of these cells.

Source: Neurology Neuroimmunology and Neuroinflammation - October 23, 2017 Category: Neurology Authors: Gandoglia, I., Ivaldi, F., Laroni, A., Benvenuto, F., Solaro, C., Mancardi, G., Kerlero de Rosbo, N., Uccelli, A. Tags: All Immunology, All Clinical Neurology, Multiple sclerosis Article Source Type: research